Biolitec, CoolTouch and Dornier market endovenous laser ablation products for use in procedures which Vnus believes infringe several of its patents. Vnus is seeking an injunction prohibiting these companies from selling these products, in addition to monetary damages.
The new lawsuit involves patents that Vnus previously asserted in 2005 against Diomed Holdings, AngioDynamics, and Vascular Solutions.
Brian Farley, president and CEO of Vnus, said: “The filing of this patent infringement suit is the next logical step in the enforcement of our intellectual property. We are committed to enforcement, while at the same time we remain open to discussing the potential opportunity for the defendant companies to obtain a limited license from Vnus.”